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Antimicrobial peptides (AMPs) are small and diverse peptides which were isolated and 
developed due to the increasing resistance to conventional antibiotics [1]. In this work, we 
focused on most recently published researches that provide us with good knowledge in 
structural features, mechanism of action, therapeutic aim, advantages and limitations, 
chemical modification approaches and carrying strategies of AMPs. This gave an idea of the 
most effective structure and other desired physicochemical features of AMPs with the best 
performance to combat pathogens. In addition, recently published papers on different 
modification strategies and carrier systems further narrowed and specified our knowledge, 
and directed us on appropriate strategies in designing a high quality modified AMP formula 
with the most influence on bioavailability and antimicrobial activity enhancement. After 
performing the selected modification method of AMP, all the risk factors that influence the 
quality of AMP will be determined within the Quality by Design framework. The confirmation 
of successful modification will be performed by different physicochemical methods and 
followed by evaluation studies of antimicrobial activity of peptide. The final step is formulation 
of AMP in solid dosage form which again will be followed by an Ishikawa diagram for 
illustrating the factors affecting the quality of an AMPs containg drug delivery system [2]. 
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